LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 7.25
(-0.82%)
CNY 7.25
(-0.82%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 67.18 Million CNY | -38.16% |
| 2022 | 108.65 Million CNY | 16.51% |
| 2021 | 93.25 Million CNY | -13.66% |
| 2020 | 108.01 Million CNY | 51.91% |
| 2019 | 71.1 Million CNY | -2.48% |
| 2018 | 72.91 Million CNY | -1.59% |
| 2017 | 74.09 Million CNY | 21.61% |
| 2016 | 60.92 Million CNY | 41.86% |
| 2015 | 42.94 Million CNY | 23.94% |
| 2014 | 34.65 Million CNY | 13.26% |
| 2013 | 30.59 Million CNY | 0.79% |
| 2012 | 30.35 Million CNY | -5.32% |
| 2011 | 32.06 Million CNY | -37.43% |
| 2010 | 51.24 Million CNY | 41.76% |
| 2009 | 36.14 Million CNY | 67.28% |
| 2008 | 21.6 Million CNY | -7.31% |
| 2007 | 23.31 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 17.7 Million CNY | -3.69% |
| 2024 Q3 | 2.97 Million CNY | -83.18% |
| 2024 Q1 | 18.38 Million CNY | 127.84% |
| 2023 Q4 | 8.07 Million CNY | 290.64% |
| 2023 FY | 67.18 Million CNY | -38.16% |
| 2023 Q3 | 2.06 Million CNY | -93.02% |
| 2023 Q1 | 23.91 Million CNY | -54.93% |
| 2023 Q2 | 29.59 Million CNY | 23.77% |
| 2022 Q4 | 53.06 Million CNY | 3135.04% |
| 2022 Q3 | 1.64 Million CNY | -94.48% |
| 2022 FY | 108.65 Million CNY | 16.51% |
| 2022 Q2 | 29.74 Million CNY | 38.36% |
| 2022 Q1 | 21.49 Million CNY | -4.38% |
| 2021 Q2 | 24.47 Million CNY | 5.95% |
| 2021 Q4 | 22.48 Million CNY | -3.08% |
| 2021 FY | 93.25 Million CNY | -13.66% |
| 2021 Q1 | 23.1 Million CNY | 18403.2% |
| 2021 Q3 | 23.19 Million CNY | -5.25% |
| 2020 Q3 | 10.59 Million CNY | -87.43% |
| 2020 Q1 | 12.31 Million CNY | 755.16% |
| 2020 FY | 108.01 Million CNY | 51.91% |
| 2020 Q4 | -126.23 Thousand CNY | -101.19% |
| 2020 Q2 | 84.24 Million CNY | 584.14% |
| 2019 Q2 | 31.53 Million CNY | 143.0% |
| 2019 Q4 | -1.87 Million CNY | -106.6% |
| 2019 FY | 71.1 Million CNY | -2.48% |
| 2019 Q1 | 12.97 Million CNY | -17.5% |
| 2019 Q3 | 28.47 Million CNY | -9.7% |
| 2018 Q2 | 20.16 Million CNY | -9.25% |
| 2018 FY | 72.91 Million CNY | -1.59% |
| 2018 Q4 | 15.73 Million CNY | 6.3% |
| 2018 Q3 | 14.79 Million CNY | -26.62% |
| 2018 Q1 | 22.22 Million CNY | -0.22% |
| 2017 FY | 74.09 Million CNY | 21.61% |
| 2017 Q3 | 17.31 Million CNY | -17.37% |
| 2017 Q4 | 22.27 Million CNY | 28.62% |
| 2017 Q2 | 20.95 Million CNY | 54.67% |
| 2017 Q1 | 13.54 Million CNY | -4.71% |
| 2016 Q4 | 14.21 Million CNY | -13.21% |
| 2016 Q1 | 9.23 Million CNY | -7.15% |
| 2016 Q2 | 21.08 Million CNY | 128.29% |
| 2016 FY | 60.92 Million CNY | 41.86% |
| 2016 Q3 | 16.38 Million CNY | -22.31% |
| 2015 Q4 | 9.94 Million CNY | -28.15% |
| 2015 Q3 | 13.84 Million CNY | 7.28% |
| 2015 Q2 | 12.9 Million CNY | 106.66% |
| 2015 Q1 | 6.24 Million CNY | -8.13% |
| 2015 FY | 42.94 Million CNY | 23.94% |
| 2014 Q4 | 6.79 Million CNY | -42.46% |
| 2014 Q3 | 11.81 Million CNY | 11.09% |
| 2014 Q2 | 10.63 Million CNY | 96.9% |
| 2014 Q1 | 5.4 Million CNY | -18.49% |
| 2014 FY | 34.65 Million CNY | 13.26% |
| 2013 Q3 | 10.23 Million CNY | 16.59% |
| 2013 Q1 | 4.94 Million CNY | -51.08% |
| 2013 Q4 | 6.62 Million CNY | -35.27% |
| 2013 FY | 30.59 Million CNY | 0.79% |
| 2013 Q2 | 8.78 Million CNY | 77.53% |
| 2012 Q1 | 4.65 Million CNY | -36.93% |
| 2012 Q2 | 8.14 Million CNY | 74.73% |
| 2012 Q3 | 7.44 Million CNY | -8.56% |
| 2012 FY | 30.35 Million CNY | -5.32% |
| 2012 Q4 | 10.11 Million CNY | 35.86% |
| 2011 FY | 32.06 Million CNY | -37.43% |
| 2011 Q4 | 7.38 Million CNY | -24.02% |
| 2011 Q3 | 9.72 Million CNY | 5.14% |
| 2011 Q2 | 9.24 Million CNY | 62.13% |
| 2011 Q1 | 5.7 Million CNY | -47.85% |
| 2010 Q3 | 9.63 Million CNY | 0.0% |
| 2010 Q4 | 10.93 Million CNY | 13.54% |
| 2010 FY | 51.24 Million CNY | 41.76% |
| 2009 FY | 36.14 Million CNY | 67.28% |
| 2008 FY | 21.6 Million CNY | -7.31% |
| 2007 FY | 23.31 Million CNY | 0.0% |